Mr. Spencer William Buck, PTA Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 901 E Tinkham Ave, Ludington, MI 49431 Phone: 231-843-2676 |
Shannon Ceara Shoop, PTA Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 901 E Tinkham Ave, Ludington, MI 49431 Phone: 231-843-2676 Fax: 231-843-2209 |
News Archive
Researchers at Georgetown University have developed a novel technology to precisely measure the sensitivity of nerve fibers that wire up the brain during development. Through use of this technology, they discovered that these fibers, or axons, possess an incredible sensitivity to molecular guidance cues that direct the axon's route to its desired destination in the brain.
No one is telling you what time to go to bed with this, but researchers are making a strong case that the duration and timing of your sleep are closely associated with whether your behavior is heart-healthy.
Oculus Innovative Sciences, Inc., a commercial medical technology company that designs, produces and markets safe and effective tissue care products based upon the Microcyn® Technology platform, today introduced the Microcyn Negative-Pressure Wound Therapy Solution™ for the U.S. professional healthcare market. Within the pH ranges of 6-7.8 desired for optimum negative-pressure wound therapy, Microcyn is intended for the irrigation and management of wounds via these advanced systems.
Keane, Inc., a U.S.-based IT services and healthcare information technology firm, today announced Keane OptimumTM 3.1 has been inspected by the Certification Commission for Health Information Technology and is certified EHR technology, IFR Stage 1 as part of the organization's Preliminary American Recovery and Reinvestment Act of 2009 certification program.
Novo Nordisk, a global healthcare company, announced today the U.S. Food and Drug Administration (FDA) approved the new drug application for Victoza® (liraglutide [rDNA origin] injection), the first once-daily human glucagon-like peptide-1 (GLP-1) analog for the treatment of type 2 diabetes. Victoza is indicated as an adjunct to diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus.
› Verified 5 days ago